WELLS FARGO & COMPANY/MN - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$149,572
-55.3%
27,445
-44.9%
0.00%
Q2 2023$334,269
+13.8%
49,817
+49.7%
0.00%
Q1 2023$293,779
+59.8%
33,270
+38.3%
0.00%
Q4 2022$183,788
+3.3%
24,056
-3.3%
0.00%
Q3 2022$178,000
-37.1%
24,872
-28.8%
0.00%
Q2 2022$283,000
-42.6%
34,924
-1.9%
0.00%
Q1 2022$493,000
-25.3%
35,603
+51.4%
0.00%
Q4 2021$660,000
-27.9%
23,515
-12.6%
0.00%
Q3 2021$915,000
-36.6%
26,891
-23.9%
0.00%
Q2 2021$1,443,000
-95.6%
35,341
-95.7%
0.00%
-100.0%
Q1 2021$32,871,000
-58.4%
816,458
-39.0%
0.01%
-63.2%
Q4 2020$79,105,000
+47.5%
1,337,827
+21.3%
0.02%
+26.7%
Q3 2020$53,638,000
+21.4%
1,102,973
+17.8%
0.02%
+15.4%
Q2 2020$44,199,000
+79.8%
936,227
+5.8%
0.01%
+62.5%
Q1 2020$24,584,000
+275.8%
884,934
+304.8%
0.01%
+300.0%
Q4 2019$6,542,000
-1.4%
218,626
+1.8%
0.00%0.0%
Q3 2019$6,636,000
+31.1%
214,768
+104.9%
0.00%
+100.0%
Q2 2019$5,061,000104,7990.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q4 2020
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders